Anvisa maintains status in the European Union for pharmaceutical supplies
Murilo Freitas - 11:28, 29 de June de 2018701
0
During the period, Anvisa and the National Health Surveillance System (SNVS) were submitted to the European Union’s audit whose main objective was “to evaluate the regulatory framework applicable to API for human use / 2014-2018 period.”
During the two weeks, the European Community auditing team, Anvisa representatives and local health surveillance visited manufacturers of IFAs in the states of São Paulo, Piauí and Minas Gerais.
